Medicaid Drug Utilization Review (DUR) Board Meeting Agenda for July 2, 2009
The New York State Medicaid Drug Utilization Review Board will meet on July 2, from 9:00 a.m. to 5:00 p.m., Meeting Room 2, Concourse, Empire State Plaza, Albany, New York.
- Update of Medication Therapy Management Program
- Update of Psychiatric Services and Clinical Knowledge Enhancement System (PSYCKES)
- Update of Prescriber Education Program
- Xyrem Presentation and Discussion of Utilization
- Restasis Presentation and Discussion of Utilization
- Growth Hormone Presentation and Discussion of Utilization
- Vusion Presentation and Discussion of Utilization
- Medicaid Pharmacy Program Updates
The Board will deliberate on Medicaid pharmacy initiatives and processes relating to appropriate, medically necessary prescribing and medical standards and criteria for the retrospective and prospective Drug Utilization Review program.
Agenda Timeline (subject to change based on meeting proceedings)
|9:00 - 9:15||Welcome and Introductions|
|9:15 - 10:15||Public Comment Period*|
|10:15 - 10:30||Update of Medication Therapy Management Program|
|10:30 - 10:45||Update of Psychiatric Services and Clinical Knowledge Enhancement System (PSYCKES)|
|10:45 - 11:00||Break|
|11:00 - 11:15||Update of Prescriber Education Program|
|11:15 - 12:00||Xyrem Presentation and Discussion of Utilization|
|12:00 - 1:00||Lunch - Executive Session|
|1:00 - 1:30||Restasis Presentation and Discussion of Utilization|
|1:30 - 2:15||Growth Hormone Presentation and Discussion of Utilization|
|2:15 - 2:30||Break|
|2:30 - 3:15||Vusion Presentation and Discussion of Utilization|
|3:15 - 3:45||Medicaid Pharmacy Program Updates|
|3:45 - 4:00||Final Comments/Adjournment|
*Interested parties must notify the Drug Utilization Review Manager at least one (1) week prior to the meeting of their request to address the Board during the public comment period. Requests may be made by calling 518-486-3209 or e-mailing firstname.lastname@example.org (please reference DUR Board). Public comments are limited to the specific topics on the agenda, must be brief (2 minutes), and the total comment period will not exceed 60 minutes. All written statements up to two (2) pages in length may be received up to one (1) week in advance of the meeting. These statements should summarize key points.
NOTE: Those wishing to submit information greater than two (2) pages in length for DUR Board consideration must do so at least two (2) weeks prior to the date of the meeting, or the Board may not have ample time to review the information.
Posted June 8, 2009